Skip to main content
Erschienen in: BMC Surgery 1/2019

Open Access 01.12.2019 | Case report

Long-term survival after anterior approach right hepatectomy combined with inferior vena cava thrombectomy using trans-diaphragmatic intrapericardial inferior vena cava occlusion: a case report and review of the literature

verfasst von: Yaodong Zhang, Zhengshan Wu, Ke Wang, Sheng Han, Changxian Li, Xiangcheng Li

Erschienen in: BMC Surgery | Ausgabe 1/2019

Abstract

Background

Presence of inferior vena cava tumor thrombosis (IVCTT) is an unfavorable factor to prognosis for patients with hepatocellular carcinoma (HCC).

Case presentation

Herein we report a case of HCC with IVC tumor thrombosis extending from the right hepatic vein (RHV) to the IVC, but it had not infiltrated the right atrium. Anterior approach right hepatectomy combined with IVC thrombectomy using trans-diaphragmatic IVC occlusion was performed for this patient. The patient is alive with disease-free at 32 months after treatment. A literature review was also performed. This case was demonstrated with the details and concepts of surgery.

Conclusion

This case suggested that surgical resection of HCC involving the IVC, but still outside the right atrium (RA), could offer satisfactory surgical outcomes in selected patients.
Hinweise
Yaodong Zhang and Zhengshan Wu contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CT
Computed tomography
HBV
Hepatitis B virus
HCC
Hepatocellular carcinoma
IVC
Inferior vena cava
TACE
Transcatheter arterial chemoembolization
TAE
Transcatheter arterial embolization
TT
Tumor thrombosis

Background

Primary hepatocellular carcinoma (HCC) accounts for 90% of primary liver cancer in China [1]. The presence of inferior vena cava tumor thrombosis (IVCTT) in patients with HCC is considered critically closely associated with poor prognosis [26]. The staging system issues by the Barcelona Clinic Liver Cancer (BCLC) / American Association for the Study of Liver Diseases (AASLD) recommends the palliative care for patients in whom unsatisfactory survival is predicted [7]. With the advances in surgical techniques and increases in the quality of perioperative care, surgical resection is associated with acceptable prognosis in HCC patients with IVCTT, especially patients who undergo R0 resection [810].
Herein, we report an HCC patient with IVCTT who underwent hepatectomy combined with IVC thrombectomy via the anterior approach and we summarized the treatments and outcomes of previous published studies that covered similar patients.

Case presentation

A 49-year-old male Chinese HCC patient with chronic hepatitis B virus (HBV) infection (having lasted more than 20 years) and cirrhosis. The laboratory results showed the following: alanine aminotransferase (ALT) 43.4 U/L, aspartate aminotransferase (AST) 35.7 U/L, alkaline phosphatase (ALP) 200.5 U/L, gamma-glutamyl transpeptidase (GGT) 188.1 U/L, bilirubin (TBil) 15.5 μmol/L, and a-fetoprotein (AFP) > 2000 μg/L. Liver function of the patient was Child-Pugh A grade and preoperative indocyanine green retention rate (ICG) was 10.5%.
Computed tomography (CT) showed a large mass about 11.3 × 9.9 cm2 in size in the right hepatic lobe, and a tumor thrombus (TT) in the right hepatic vein (RHV) extending into the IVC (Fig. 1a and b).
Using both his medical history and imaging findings, he was diagnosed with HCC associated with IVCTT. The clinical stage was BCLC stage C. The patient had no symptoms of right heart failure or pulmonary embolization at admission. Considering that the patient had normal hepatic function without distant metastasis, anterior approach right hepatectomy combined with IVC thrombectomy using trans-diaphragmatic intrapericardial IVC occlusion was planned for this patient (Fig. 1c).
Surgery was performed via a subcostal inverse-L-shaped incision. At laparotomy, a tumor located in the right lobe of cirrhotic liver and no detectable ascites or peritoneal metastasis was observed. After the right hepatic artery and the right portal vein branch were ligated, hepatic parenchymal resection was performed using the clamp-crushing technique with inflow occlusion (Pringle’s maneuver) following the demarcation (Fig. 2a). Then the suprarenal IVC and portal vein were dissected and taped from the caudate lobe (Fig. 2b). The retrohepatic IVC below the confluence of the common channel of the left and middle hepatic veins was encircled by a vascular clamp. The diaphragm was transected via a vertical incision exposing the right atrial appendage. Then intraoperative ultrasonography was used to show that a TT in the RHV, involving the IVC, but it had not entered in the right atrium. The supradiaphragmatic IVC was encircled though trans-diaphragmatic intrapericardial IVC (Fig. 2c). The sequence of total hepatic vascular exclusion is shown in Fig. 2d and the IVTT was then removed en bloc successfully with Babcock forceps, the whole removal of IVCTT with IVC exclusion cost 20 min. The total operation required 481 min and the intraoperative hemorrhage was 900 ml.
The macroscopic findings of tumor measured 10 × 11 × 13 cm3 and the TT measured 3.0 × 2.0 cm2 (Fig. 3a). Postoperative histological diagnosis showed moderately differentiated HCC (grade II-III Edmondson) had invaded the right hepatic vein with hepatic fibrosis and intravascular tumor thrombus. No positive resection margins or local lymph node metastasis were observed microscopically (Fig. 3b). The TNM stage was T3bN0M0.
Postoperative recovery was uneventful. The patient was discharged with few adverse events after the operation. The patient was disease-free at 32 months after the initial treatment (Fig. 3c).

Discussion and conclusions

Despite advances in perioperative therapy and multidisciplinary therapy, IVCTT-presenting HCC is still a significant factor for a dismal prognosis of HCC patients [3, 11, 12]. The median survival time after surgical resection for HCC with IVCTT was significantly better than that without surgical resection or in patients treated with sorafenib (47.4 vs 4/10.7 months) [3, 7]. Regarding prognosis, we reviewed 33 case reports of HCC with IVCTT (Table 1) and found the mean patient age to be 55.8 ± 15.4 years, and the mean time that elapsed between diagnosis and treatment was 20 ± 22.8 months in the 17 patients who underwent liver resection and TT, the mean time that elapsed between diagnosis and treatment was 9 ± 4.5 months in the 7 patients who underwent resection of TT alone, and the mean time that elapsed between diagnosis and treatment was 10.4 ± 12.3 months in the 12 patients who received other oncology therapy. These data indicated that aggressive radical resection of thrombus combined with hepatectomy or tumor thrombus extraction alone, might yield better survival than other non-surgical treatment.
Table 1
Reported cases of hepatocellular carcinoma with IVC involvement
No
Literature
Age/Sex
Location
Size
IVC Involvement
Treatment Technique
Additional Treatment
Survival
Outcome
1
Tastekin [13]
24/male
Rt lobe
6 × 6 × 4 cm
III LV
Resection of liver tumor
Resection of tumor thrombus
18 mo
Dead
2
Ehrich [14]
62/male
Lt lobe
ND
III RA
Resection of tumor thrombus
Radiation therapy
12 mo
Alive
3
Li [15]
66/male
Rt lobe
12 cm
III RA
Resection of liver tumor and tumor thrombus
No
6 mo
Dead
4
Oncale [16]
76/male
Rt lobe
12 × 8 cm
II
Sorafenib
No
14 mo
Dead
5
Miller [17]
30/male
Extensive involvement
ND
III RA
Resection of tumor thrombus
Radiation therapy and immunotherapy
6 mo
Alive
6
Chang [4]
57/male
RAS
9.6 × 8.6 cm
III RA
Thalidomide
No
12 mo
Alive
76/male
MHV
2 cm
III RA
TACE
Thalidomide
18 mo
Dead
67/female
Seg5, Seg8
7 cm
III RA
Thalidomide
No
5 mo
Alive
7
Inoue [39]
67/male
Seg2, Seg3
1.2 cm
III RA
Resection of liver tumor and tumor thrombus
No
27 mo
Alive
8
Luo [18]
35/male
Lt lobe, RAS
ND
III RA
Percutaneous microwave ablation
No
6 mo
Dead
9
Goto [19]
36/female
Rt lobe
ND
III RA
Resection of tumor thrombus
TACE
7 mo
Dead
10
Kawakam [20]
66/female
Extensive involvement
ND
III RA
Symptomatic treatment
TACE
5 mo
Dead
11
Sun [21]
45/male
Lt lobe
ND
III RA
TACE
No
46 mo
Alive
12
Georgen [22]
22/female
Seg7
6 cm
III RA
Resection of liver tumor and tumor thrombus
No
30 mo
Dead
13
Noguchi [23]
66/male
Rt lobe
2 cm
III RA
Symptomatic treatment
No
1 mo
Dead
14
Ohta [43]
60/male
Rt lobe
ND
III RA
Resection of liver tumor and tumor thrombus
Sorafenib
10 mo
Alive
15
Sengodan [24]
44/male
Rt lobe
5.6 × 7.6 × 5.5 cm
III RA
Sorafenib
Anticoagulation
2 mo
Dead
16
Hayashida [25]
72/male
Lt lobe
ND
III RA
Resection of tumor thrombus
TACE
6 mo
Dead
17
Sawada [26]
62/male
Extensive involvement
ND
III RA
Glypican-3-derived peptide vaccination
TACE, sorafenib
56 d
Dead
18
Shivathirthan [40]
71/male
Seg 7
ND
III RA
Resection of liver tumor and tumor thrombus
TACE
ND
ND
19
Miyazawa [27]
55/male
RAS
7 cm
III RA
Resection of liver tumor and tumor thrombus
No
12 mo
Alive
20
Li [28]
64/male
Seg 6, Seg7
5.3 × 3.6 cm
III RA
Resection of liver tumor and tumor thrombus
No
6 mo
Dead
21
Wu [42]
42/male
RAS
1.5 cm
III RA
Resection of liver tumor and tumor thrombus
TACE
14 mo
Dead
22
Giuliani [29]
47/male
Lt lobe
Mutiple
III RA
External beam radiation therapy
No
7 mo
Dead
23
Leo [30]
45/male
Lt lobe
ND
III RA
Resection of liver tumor and tumor thrombus
No
6 mo
Alive
24
Florman [3]
55/male
Lt lobe
18 × 3 × 7 cm
III RA
Resection of liver tumor and tumor thrombus
No
3 mo
Alive
25
Sung [31]
71/male
Rt lobe
ND
III RA
Resection of tumor thrombus
Sorafenib
7 mo
Alive
26
Ohwada [32]
77/female
LLS
10 cm
III RA
Resection of liver tumor and tumor thrombus
No
3 mo
Alive
27
Lin [33]
57/male
Rt lobe
4.5 cm
III RA
Resection of liver tumor and tumor thrombus
No
3 D
Dead
28
Yogita [34]
61/male
LMS
3 cm
III RA
Resection of liver tumor and tumor thrombus
No
56 mo
Dead
29
Masaki [35]
47/male
Seg 8
3 × 2.5 × 2 cm
III RA
Resection of tumor thrombus
TAE and radiation therapy
8 mo
Dead
48/male
Seg 7
ND
III LP
Resection of tumor thrombus in the IVC and LPA
TAE
29 D
Dead
30
Kashima [20]
66/male
Rt lobe
10 × 7 cm
III RA
Resection of liver tumor and tumor thrombus
TACE
59 mo
Alive
31
Fujisaki [36]
38/female
LLS
8 × 8 cm
III RA
Resection of liver tumor and tumor thrombus
No
15 mo
Alive
32
Dazai [37]
42/male
Rt lobe
ND
III RA
TACE
No
7 mo
Dead
33
Kurahashi [38]
81/male
Rt lobe
11.5 cm
III RA
Resection of liver tumor and tumor thrombus
Oncologic treatment
72 mo
Alive
IVC inferior vena cava, LLS left lateral segment, LMS left medial segment, Lt left, MHV middle hepatic vein, ND not described, RA right atrium, RAS right anterior segment, Rt right, Seg segment, TACE transcatheter arterial chemoembolization, TAE transcatheter arterial embolization, LPA Left pulmonary artery, LP left pulmonary, mo months, II type II (mentioned in Fig. 4), III type III (mentioned in Fig. 4)
A previous clinical study defined the subtypes of IVCTT-presenting HCC into three types based on the anatomic locations of the IVCTT and heart. The TT located within the subdiaphragmatic IVC was defined as the inferior hepatic type (Type I) (Fig. 4a), and the IVCTT extended above the diaphragm, but it had not infiltrated the RA. It was defined as superior hepatic type (Type II) (Fig. 4b), for the intracardiac type (Type III). The TT extended over the diaphragm and had entered the RA (Fig. 4c) [12].
With the advances in surgical techniques, increasing numbers of successful simultaneous resection of HCC with IVC tumor thrombosis have been reported [39]. Kokudo et al. reported that the 1-year and 3-year survival rates were 81 and 32%, respectively, and the median survival time was 16.7 months [8]. Wang et al. reported that the 1-year, 3-year, and 5-year survival rates were 68, 22.5, and 13.5% and the median survival time was 19 months [10]. These data indicated that resection of HCC and IVCTT might result in better survival than other non-surgical therapies.
Cardiopulmonary bypasses (CPB) and total hepatic vascular exclusion (THVE) have been reported in most previous resection cases [4043]. However, these technologies have reportedly been associated with the risk of massive hemorrhage and severe vascular injury. Although other new technologies, such as venous bypass, total circulatory arrest with exsanguinations, and concomitant hypothermia, can reduce these risks, technical complexity is still the main limitation of these procedures [42, 44]. The basis of our technique is that the IVCTT undergo no or minimal adhesion to the venous wall on any macroscopic scale. Similar ideas have been mentioned in two previous articles. We have simplified the surgery procedure and difficulty based on the new surgical concepts. It has been suggested that this surgical procedure could be suitable for HCC patients with IVCTT extended above the diaphragm without entering the RA, and it could reduce the risk of bleeding and vascular injury to a considerable intent.
No-touch surgery is difficult to perform given the anatomical characteristics of the liver [45]. Recent studies have confirmed that tumor cells diffuse more easily through the portal vein or hepatic vein during the conventional hepatectomy than through other veins and resulting in early recurrence [46, 47]. Recently, some studies have reported that anterior approach hepatectomy, because involves less manipulation of the liver, can reduce the rate of recurrence of postoperative liver cancer, and extend patient survival [48]. Clinical, randomized controlled studies reported that half-hepatectomy in the anterior approach significantly reduced the risk of blood loss, improved the survival rate, ensured surgical vision, and reduced the perioperative mortality rate [49].
During this procedure, a process termed the peeling-off technique was performed because tumor thromboses do not adhere to the wall of the IVC. Previous studies have proved that the peeling off technique can improve the surgical outcome of HCC with portal vein tumor thrombus [50, 51]. We reported the resection for HCC with IVCTT using the peeling off technique and the long-term survival outcomes are comparable to the current case reports. The low incidence of IVC tumor thrombus in HCC should not preclude the development of new surgical approaches because the peeling-off technique is a minimally invasive approach and deserves further investigation.
In this case, because the IVCTT is above the diaphragm but still outside the RA, the intrathoracic IVC is approached by an abdominal incision of the diaphragm, without the need for a median sternotomy or thoracotomy [52, 53]. This method prevents any need for splitting the sternum and also reduced surgical trauma, keeping the IVC hiatus and preserved the normal anatomical structures, and offered good surgical exposure.
In conclusion, radical resection of both HCC and IVCTT could be a practical surgical option and useful therapeutic modality for achieving long-term survival or HCC patients with IVCTT extending to the IVC, especially for those IVCTT extending over the diaphragm but outside the RA.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. The ethics committee of the First Affiliated Hospital of Nanjing medical University has approved this study.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–76.CrossRefPubMed El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–76.CrossRefPubMed
2.
Zurück zum Zitat Lee IJ, Chung JW, Kim HC, et al. Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors. J Vasc Interv Radiol. 2009;20(1):22–9.CrossRefPubMed Lee IJ, Chung JW, Kim HC, et al. Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors. J Vasc Interv Radiol. 2009;20(1):22–9.CrossRefPubMed
3.
Zurück zum Zitat Florman S, Weaver M, Primeaux P, et al. Aggressive resection of hepatocellular carcinoma with right atrial involvement. Am Surg. 2009;75(11):1104–8.PubMed Florman S, Weaver M, Primeaux P, et al. Aggressive resection of hepatocellular carcinoma with right atrial involvement. Am Surg. 2009;75(11):1104–8.PubMed
4.
Zurück zum Zitat Chang JY, Ka WS, Chao TY, et al. Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology. 2004;67(3–4):320–6.CrossRefPubMed Chang JY, Ka WS, Chao TY, et al. Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology. 2004;67(3–4):320–6.CrossRefPubMed
5.
Zurück zum Zitat Koo JE, Kim JH, Lim YS, et al. Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys. 2010;78(1):180–7.CrossRefPubMed Koo JE, Kim JH, Lim YS, et al. Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys. 2010;78(1):180–7.CrossRefPubMed
6.
Zurück zum Zitat Cuevas C, Raske M, Bush WH, et al. Imaging primary and secondary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging. Curr Probl Diagn Radiol. 2006;35(3):90–101.CrossRefPubMed Cuevas C, Raske M, Bush WH, et al. Imaging primary and secondary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging. Curr Probl Diagn Radiol. 2006;35(3):90–101.CrossRefPubMed
7.
Zurück zum Zitat Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.CrossRef Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.CrossRef
8.
Zurück zum Zitat Kokudo T, Hasegawa K, Yamamoto S, et al. Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis. J Hepatol. 2014;61(3):583–8.CrossRefPubMed Kokudo T, Hasegawa K, Yamamoto S, et al. Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis. J Hepatol. 2014;61(3):583–8.CrossRefPubMed
9.
Zurück zum Zitat Wakayama K, Kamiyama T, Yokoo H, et al. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol. 2013;11:259.CrossRefPubMedPubMedCentral Wakayama K, Kamiyama T, Yokoo H, et al. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol. 2013;11:259.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wang Y, Yuan L, Ge RL, et al. Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol. 2013;20(3):914–22.CrossRefPubMed Wang Y, Yuan L, Ge RL, et al. Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol. 2013;20(3):914–22.CrossRefPubMed
11.
Zurück zum Zitat Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005;137(4):403–10.CrossRefPubMed Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005;137(4):403–10.CrossRefPubMed
12.
Zurück zum Zitat Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol. 2010;17(5):1219–25.CrossRefPubMedPubMedCentral Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol. 2010;17(5):1219–25.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Tastekin E, Usta U, Ege T, et al. Cardiac metastasis of hepatocellular carcinoma in a young non-cirrhotic patient, to the left ventricle. Ann Hepatol. 2012;11(3):392–4.CrossRefPubMed Tastekin E, Usta U, Ege T, et al. Cardiac metastasis of hepatocellular carcinoma in a young non-cirrhotic patient, to the left ventricle. Ann Hepatol. 2012;11(3):392–4.CrossRefPubMed
14.
Zurück zum Zitat Ehrich DA, Widmann JJ, Berger RL, et al. Intracavitary cardiac extension of hepatoma. Ann Thorac Surg. 1975;19(2):206–11.CrossRefPubMed Ehrich DA, Widmann JJ, Berger RL, et al. Intracavitary cardiac extension of hepatoma. Ann Thorac Surg. 1975;19(2):206–11.CrossRefPubMed
15.
Zurück zum Zitat Li AJ, Yuan H, Yin L, et al. Cavoatrial thrombectomy in hepatocellular carcinoma with tumor thrombus in the vena cava and atrium without the use of cardiopulmonary bypass. Ann Vasc Surg. 2014;28(6):1565 e1565–8.CrossRef Li AJ, Yuan H, Yin L, et al. Cavoatrial thrombectomy in hepatocellular carcinoma with tumor thrombus in the vena cava and atrium without the use of cardiopulmonary bypass. Ann Vasc Surg. 2014;28(6):1565 e1565–8.CrossRef
16.
Zurück zum Zitat Oncale M, Lewis B. Hepatocellular carcinoma with extension to the heart via the inferior vena cava. Proc (Bayl Univ Med Cent). 2015;28(2):229–30.CrossRef Oncale M, Lewis B. Hepatocellular carcinoma with extension to the heart via the inferior vena cava. Proc (Bayl Univ Med Cent). 2015;28(2):229–30.CrossRef
17.
Zurück zum Zitat Miller DL, Katz NM, Pallas RS. Hepatoma presenting as a right atrial mass. Am Heart J. 1987;114(4 Pt 1):906–8.CrossRefPubMed Miller DL, Katz NM, Pallas RS. Hepatoma presenting as a right atrial mass. Am Heart J. 1987;114(4 Pt 1):906–8.CrossRefPubMed
18.
Zurück zum Zitat Luo X, Zhang B, Dong S, et al. Hepatocellular carcinoma with tumor Thrombus occupying the right atrium and portal vein: a case report and literature review. Medicine (Baltimore). 2015;94(34):e1049.CrossRef Luo X, Zhang B, Dong S, et al. Hepatocellular carcinoma with tumor Thrombus occupying the right atrium and portal vein: a case report and literature review. Medicine (Baltimore). 2015;94(34):e1049.CrossRef
19.
Zurück zum Zitat Goto H, Kaneko Y, Utoh J, et al. Surgery of hepatoma with intracavitary cardiac extension. Heart Vessel. 1986;2(1):60–2.CrossRef Goto H, Kaneko Y, Utoh J, et al. Surgery of hepatoma with intracavitary cardiac extension. Heart Vessel. 1986;2(1):60–2.CrossRef
20.
Zurück zum Zitat Kashima Y, Miyazaki M, Ito H, et al. Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol. 1999;14(9):922–7.CrossRefPubMed Kashima Y, Miyazaki M, Ito H, et al. Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol. 1999;14(9):922–7.CrossRefPubMed
21.
Zurück zum Zitat Sun JH, Zhang YL, Nie CH, et al. Long-term survival after chemoembolization of metastatic right atrial tumor thrombus as a presenting feature of hepatocellular carcinoma: a case study. Oncol Lett. 2012;3(5):975–7.CrossRefPubMedPubMedCentral Sun JH, Zhang YL, Nie CH, et al. Long-term survival after chemoembolization of metastatic right atrial tumor thrombus as a presenting feature of hepatocellular carcinoma: a case study. Oncol Lett. 2012;3(5):975–7.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Georgen M, Regimbeau JM, Kianmanesh R, et al. Removal of hepatocellular carcinoma extending in the right atrium without extracorporal bypass. J Am Coll Surg. 2002;195(6):892–4.CrossRefPubMed Georgen M, Regimbeau JM, Kianmanesh R, et al. Removal of hepatocellular carcinoma extending in the right atrium without extracorporal bypass. J Am Coll Surg. 2002;195(6):892–4.CrossRefPubMed
23.
Zurück zum Zitat Noguchi H, Hirai K, Itano S, et al. Small hepatocellular carcinoma with intravascular tumor growth into the right atrium. J Gastroenterol. 1994;29(1):41–6.CrossRefPubMed Noguchi H, Hirai K, Itano S, et al. Small hepatocellular carcinoma with intravascular tumor growth into the right atrium. J Gastroenterol. 1994;29(1):41–6.CrossRefPubMed
24.
Zurück zum Zitat Sengodan P, Grewal H, Gandhi S. Invasive hepatocellular carcinoma with recurrent pulmonary embolism: use of AngioVac cannula thrombectomy device for mechanical aspiration. J Invasive Cardiol. 2014;26(7):E100–3.PubMed Sengodan P, Grewal H, Gandhi S. Invasive hepatocellular carcinoma with recurrent pulmonary embolism: use of AngioVac cannula thrombectomy device for mechanical aspiration. J Invasive Cardiol. 2014;26(7):E100–3.PubMed
25.
Zurück zum Zitat Hayashida K, Okumura S, Kawase T. Right atrial obstruction due to cardiac extension of hepatocellular carcinoma. Asian Cardiovasc Thorac Ann. 2014;22(4):465–8.CrossRefPubMed Hayashida K, Okumura S, Kawase T. Right atrial obstruction due to cardiac extension of hepatocellular carcinoma. Asian Cardiovasc Thorac Ann. 2014;22(4):465–8.CrossRefPubMed
26.
Zurück zum Zitat Sawada Y, Yoshikawa T, Fujii S, et al. Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case. Hum Vaccin Immunother. 2013;9(6):1228–33.CrossRefPubMedPubMedCentral Sawada Y, Yoshikawa T, Fujii S, et al. Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case. Hum Vaccin Immunother. 2013;9(6):1228–33.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Miyazawa M, Torii T, Asano H, et al. Does a surgery for hepatocellular carcinoma with tumor thrombus highly occupying in the right atrium have significance? A case report and review of the literature. Hepatogastroenterology. 2005;52(61):212–6.PubMed Miyazawa M, Torii T, Asano H, et al. Does a surgery for hepatocellular carcinoma with tumor thrombus highly occupying in the right atrium have significance? A case report and review of the literature. Hepatogastroenterology. 2005;52(61):212–6.PubMed
28.
Zurück zum Zitat Li SS, Jian LL, Gang PB, et al. Removal of hepatocellular carcinoma extending into the right atrium with extracorporeal circulation. Hepatogastroenterology. 2012;59(117):1591–3.PubMed Li SS, Jian LL, Gang PB, et al. Removal of hepatocellular carcinoma extending into the right atrium with extracorporeal circulation. Hepatogastroenterology. 2012;59(117):1591–3.PubMed
29.
Zurück zum Zitat Giuliani ME, Knox J, Dawson LA. Malignant intracardiac thrombus from hepatocellular carcinoma treated with external beam radiation therapy. J Palliat Med. 2010;13(10):1293–5.CrossRefPubMed Giuliani ME, Knox J, Dawson LA. Malignant intracardiac thrombus from hepatocellular carcinoma treated with external beam radiation therapy. J Palliat Med. 2010;13(10):1293–5.CrossRefPubMed
30.
Zurück zum Zitat Leo F, Rapisarda F, Stefano PL, et al. Cavo-atrial thrombectomy combined with left hemi-hepatectomy for vascular invasion from hepatocellular carcinoma on diseased liver under hypothermic cardio-circulatory arrest. Interact Cardiovasc Thorac Surg. 2010;10(3):473–5.CrossRefPubMed Leo F, Rapisarda F, Stefano PL, et al. Cavo-atrial thrombectomy combined with left hemi-hepatectomy for vascular invasion from hepatocellular carcinoma on diseased liver under hypothermic cardio-circulatory arrest. Interact Cardiovasc Thorac Surg. 2010;10(3):473–5.CrossRefPubMed
31.
Zurück zum Zitat Sung AD, Cheng S, Moslehi J, et al. Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature. Am J Cardiol. 2008;102(5):643–5.CrossRefPubMed Sung AD, Cheng S, Moslehi J, et al. Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature. Am J Cardiol. 2008;102(5):643–5.CrossRefPubMed
32.
Zurück zum Zitat Ohwada S, Takahashi T, Tsutsumi H, et al. Hepatocellular carcinoma with a tumour thrombus extending to the tricuspid valve: report of a successful en bloc resection. Hepatogastroenterology. 2008;55(84):903–6.PubMed Ohwada S, Takahashi T, Tsutsumi H, et al. Hepatocellular carcinoma with a tumour thrombus extending to the tricuspid valve: report of a successful en bloc resection. Hepatogastroenterology. 2008;55(84):903–6.PubMed
33.
Zurück zum Zitat Lin HH, Hsieh CB, Chu HC, et al. Acute pulmonary embolism as the first manifestation of hepatocellular carcinoma complicated with tumor thrombi in the inferior vena cava: surgery or not? Dig Dis Sci. 2007;52(6):1554–7.CrossRefPubMed Lin HH, Hsieh CB, Chu HC, et al. Acute pulmonary embolism as the first manifestation of hepatocellular carcinoma complicated with tumor thrombi in the inferior vena cava: surgery or not? Dig Dis Sci. 2007;52(6):1554–7.CrossRefPubMed
34.
Zurück zum Zitat Yogita S, Tashiro S, Harada M, et al. Hepatocellular carcinoma with extension into the right atrium: report of a successful liver resection by hepatic vascular exclusion using cardiopulmonary bypass. J Med Investig. 2000;47(3–4):155–60. Yogita S, Tashiro S, Harada M, et al. Hepatocellular carcinoma with extension into the right atrium: report of a successful liver resection by hepatic vascular exclusion using cardiopulmonary bypass. J Med Investig. 2000;47(3–4):155–60.
35.
Zurück zum Zitat Masaki N, Hayashi S, Maruyama T, et al. Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries. Cancer Chemother Pharmacol. 1994;33(Suppl):S7–11.CrossRefPubMed Masaki N, Hayashi S, Maruyama T, et al. Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries. Cancer Chemother Pharmacol. 1994;33(Suppl):S7–11.CrossRefPubMed
36.
Zurück zum Zitat Fujisaki M, Kurihara E, Kikuchi K, et al. Hepatocellular carcinoma with tumor thrombus extending into the right atrium: report of a successful resection with the use of cardiopulmonary bypass. Surgery. 1991;109(2):214–9.PubMed Fujisaki M, Kurihara E, Kikuchi K, et al. Hepatocellular carcinoma with tumor thrombus extending into the right atrium: report of a successful resection with the use of cardiopulmonary bypass. Surgery. 1991;109(2):214–9.PubMed
37.
Zurück zum Zitat Dazai Y, Katoh T, Katoh I, et al. Effectiveness of chemoembolization therapy for metastatic right atrial tumor thrombus associated with hepatocellular carcinoma. Chest. 1989;96(2):434–6.CrossRefPubMed Dazai Y, Katoh T, Katoh I, et al. Effectiveness of chemoembolization therapy for metastatic right atrial tumor thrombus associated with hepatocellular carcinoma. Chest. 1989;96(2):434–6.CrossRefPubMed
38.
Zurück zum Zitat Kurahashi S, Sano T, Natsume S, et al. Surgical treatment after hepatic arterial infusion chemotherapy for hepatocellular carcinoma extending into the right atrium. Surg Case Rep. 2015;1(1):47.CrossRefPubMedPubMedCentral Kurahashi S, Sano T, Natsume S, et al. Surgical treatment after hepatic arterial infusion chemotherapy for hepatocellular carcinoma extending into the right atrium. Surg Case Rep. 2015;1(1):47.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Inoue Y, Hayashi M, Katsumata T, et al. Hepatocellular carcinoma with right atrial tumor thrombus: report of a case. Surg Today. 2011;41(8):1122–9.CrossRefPubMed Inoue Y, Hayashi M, Katsumata T, et al. Hepatocellular carcinoma with right atrial tumor thrombus: report of a case. Surg Today. 2011;41(8):1122–9.CrossRefPubMed
40.
Zurück zum Zitat Shivathirthan N, Shimoda M, Kosuge T, et al. Recurrent hepatocellular carcinoma with tumor thrombus in right atrium - report of a successful liver resection with tumor thrombectomy using total hepatic vascular exclusion without concomitant cardiopulmonary bypass. Hepatogastroenterology. 2012;59(115):872–4.PubMed Shivathirthan N, Shimoda M, Kosuge T, et al. Recurrent hepatocellular carcinoma with tumor thrombus in right atrium - report of a successful liver resection with tumor thrombectomy using total hepatic vascular exclusion without concomitant cardiopulmonary bypass. Hepatogastroenterology. 2012;59(115):872–4.PubMed
41.
Zurück zum Zitat Kawamoto K, Eguchi H, Wada H, et al. A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium. Gan To Kagaku Ryoho. 2011;38(12):2490–2.PubMed Kawamoto K, Eguchi H, Wada H, et al. A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium. Gan To Kagaku Ryoho. 2011;38(12):2490–2.PubMed
42.
Zurück zum Zitat Wu CC, Hseih S, Ho WM, et al. Surgical treatment for recurrent hepatocellular carcinoma with tumor thrombi in right atrium: using cardiopulmonary bypass and deep hypothermic circulatory arrest. J Surg Oncol. 2000;74(3):227–31.CrossRefPubMed Wu CC, Hseih S, Ho WM, et al. Surgical treatment for recurrent hepatocellular carcinoma with tumor thrombi in right atrium: using cardiopulmonary bypass and deep hypothermic circulatory arrest. J Surg Oncol. 2000;74(3):227–31.CrossRefPubMed
43.
Zurück zum Zitat Ohta M, Nakanishi C, Kawagishi N, et al. Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature. Surg Case Rep. 2016;2(1):110.CrossRefPubMedPubMedCentral Ohta M, Nakanishi C, Kawagishi N, et al. Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature. Surg Case Rep. 2016;2(1):110.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Azoulay D, Andreani P, Maggi U, et al. Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg. 2006;244(1):80–8.CrossRefPubMedPubMedCentral Azoulay D, Andreani P, Maggi U, et al. Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg. 2006;244(1):80–8.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–92.CrossRefPubMed Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–92.CrossRefPubMed
46.
Zurück zum Zitat Yamanaka N, Okamoto E, Fujihara S, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer. 1992;70(9):2263–7.CrossRefPubMed Yamanaka N, Okamoto E, Fujihara S, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer. 1992;70(9):2263–7.CrossRefPubMed
47.
Zurück zum Zitat Matsumata T, Kanematsu T, Takenaka K, et al. Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres. Surgery. 1989;105(2 Pt 1):188–91.PubMed Matsumata T, Kanematsu T, Takenaka K, et al. Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres. Surgery. 1989;105(2 Pt 1):188–91.PubMed
48.
Zurück zum Zitat Li L, Wang HQ, Wang Q, et al. Anterior vs conventional approach hepatectomy for large liver cancer: a meta-analysis. World J Gastroenterol. 2014;20(45):17235–43.CrossRefPubMedPubMedCentral Li L, Wang HQ, Wang Q, et al. Anterior vs conventional approach hepatectomy for large liver cancer: a meta-analysis. World J Gastroenterol. 2014;20(45):17235–43.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244(2):194–203.CrossRefPubMedPubMedCentral Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244(2):194–203.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Inoue Y, Hasegawa K, Ishizawa T, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery. 2009;145(1):9–19.CrossRefPubMed Inoue Y, Hasegawa K, Ishizawa T, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery. 2009;145(1):9–19.CrossRefPubMed
51.
Zurück zum Zitat Yamamoto S, Hasegawa K, Inoue Y, et al. Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg. 2015;261(5):e123–5.CrossRefPubMed Yamamoto S, Hasegawa K, Inoue Y, et al. Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg. 2015;261(5):e123–5.CrossRefPubMed
52.
Zurück zum Zitat Miyazaki M, Ito H, Nakagawa K, et al. An approach to intrapericardial inferior vena cava through the abdominal cavity, without median sternotomy, for total hepatic vascular exclusion. Hepatogastroenterology. 2001;48(41):1443–6.PubMed Miyazaki M, Ito H, Nakagawa K, et al. An approach to intrapericardial inferior vena cava through the abdominal cavity, without median sternotomy, for total hepatic vascular exclusion. Hepatogastroenterology. 2001;48(41):1443–6.PubMed
53.
Zurück zum Zitat Chen TW, Tsai CH, Chou SJ, et al. Intrapericardial isolation of the inferior vena cava through a transdiaphragmatic pericardial window for tumor resection without sternotomy or thoracotomy. Eur J Surg Oncol. 2007;33(2):239–42.CrossRefPubMed Chen TW, Tsai CH, Chou SJ, et al. Intrapericardial isolation of the inferior vena cava through a transdiaphragmatic pericardial window for tumor resection without sternotomy or thoracotomy. Eur J Surg Oncol. 2007;33(2):239–42.CrossRefPubMed
Metadaten
Titel
Long-term survival after anterior approach right hepatectomy combined with inferior vena cava thrombectomy using trans-diaphragmatic intrapericardial inferior vena cava occlusion: a case report and review of the literature
verfasst von
Yaodong Zhang
Zhengshan Wu
Ke Wang
Sheng Han
Changxian Li
Xiangcheng Li
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Surgery / Ausgabe 1/2019
Elektronische ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-019-0568-7

Weitere Artikel der Ausgabe 1/2019

BMC Surgery 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.